Skip to main content
Log in

Microbiological Profile and Antimicrobial Susceptibility in Surgical Site Infections Following Hollow Viscus Injury

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Introduction

The purpose of this study was to assess the microbiological profile, antimicrobial susceptibility, and adequacy of the empiric antibiotic therapy in surgical site infections (SSI) following traumatic hollow viscus injury (HVI).

Methods

This is a retrospective study of patients admitted with an HVI from March 2003 to July 2009. SSI was defined as a wound infection or intra-abdominal collection confirmed by positive cultures and requiring percutaneous or surgical drainage.

Results

A total of 91 of 667 (13.6%) patients with an HVI developed an SSI confirmed by positive culture. Mean age was 33.0 ± 14.1 years, mean Injury Severity Score (ISS) was 17.7 ± 9.6, 91.2% were male, and 80.2% had sustained penetrating injuries. The SSI consisted of 65 intra-abdominal collections and 26 wound infections requiring intervention. The most commonly isolated species in the presence of a colonic injury was Escherichia coli (64.7%), Enterococcus spp. (41.2%), and Bacteroides (29.4%), and in the absence of a colonic perforation, Enterococcus spp. and Enterobacter cloacae (both 38.9%). Susceptibility rates of E. coli and E. cloacae, respectively, were 38% and 8% for ampicillin/sulbactam, 82% and 4% for cefazolin, 96% and 92% for cefoxitin, with both 92% to piperacillin/tazobactam, and 100% to ertapenem. The initial empirical antibiotic therapy adequately targeted the pathogens in 51.6% of patients who developed an SSI.

Conclusion

The distribution of the microorganisms isolated from SSIs differed significantly according to whether or not a colonic injury was present. Empiric antibiotic treatment was inadequate in upwards of 50% of patients who developed an SSI. Further investigation is warranted to determine the optimal empiric antibiotic regimen for reducing the rate of postoperative SSI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Morales CH, Villegas MI, Villavicencio R, Gonzalez G, Perez LF, Pena AM, Vanegas LE. Intra-abdominal infection in patients with abdominal trauma. Arch Surg 2004;139:1278-1285; discussion 1285.

    Article  PubMed  Google Scholar 

  2. Salim A, Teixeira PG, Inaba K, Brown C, Browder T, Demetriades D. Analysis of 178 penetrating stomach and small bowel injuries. World J Surg 2008;32:471-475.

    Article  PubMed  Google Scholar 

  3. Hofstetter SR, Pachter HL, Bailey AA, Coppa GF. A prospective comparison of two regimens of prophylactic antibiotics in abdominal trauma: cefoxitin versus triple drug. J Trauma 1984;24:307-310.

    Article  CAS  PubMed  Google Scholar 

  4. Delgado G, Jr., Barletta JF, Kanji S, Tyburski JG, Wilson RF, Devlin JW. Characteristics of prophylactic antibiotic strategies after penetrating abdominal trauma at a level I urban trauma center: a comparison with the East guidelines. J Trauma 2002;53:673-678.

    Article  CAS  PubMed  Google Scholar 

  5. O'Neill PA, Kirton OC, Dresner LS, Tortella B, Kestner MM. Analysis of 162 colon injuries in patients with penetrating abdominal trauma: concomitant stomach injury results in a higher rate of infection. J Trauma 2004;56:304-312; discussion 312-303.

    Article  PubMed  Google Scholar 

  6. Croce MA, Fabian TC, Stewart RM, Pritchard FE, Minard G, Kudsk KA. Correlation of abdominal trauma index and injury severity score with abdominal septic complications in penetrating and blunt trauma. J Trauma 1992;32:380-387; discussion 387-388.

    Article  CAS  PubMed  Google Scholar 

  7. Croce MA, Fabian TC, Patton JH, Jr., Lyden SP, Melton SM, Minard G, Kudsk KA, Pritchard FE. Impact of stomach and colon injuries on intra-abdominal abscess and the synergistic effect of hemorrhage and associated injury. J Trauma 1998;45:649-655.

    Article  CAS  PubMed  Google Scholar 

  8. Demetriades D, Lakhoo M, Pezikis A, Charalambides D, Pantanowitz D, Sofianos C. Short-course antibiotic prophylaxis in penetrating abdominal injuries: ceftriaxone versus cefoxitin. Injury 1991;22:20-24.

    Article  CAS  PubMed  Google Scholar 

  9. Nichols RL, Smith JW, Klein DB, Trunkey DD, Cooper RH, Adinolfi MF, Mills J. Risk of infection after penetrating abdominal trauma. N Engl J Med 1984;311:1065-1070.

    Article  CAS  PubMed  Google Scholar 

  10. Kirton OC, O'Neill PA, Kestner M, Tortella BJ. Perioperative antibiotic use in high-risk penetrating hollow viscus injury: a prospective randomized, double-blind, placebo-control trial of 24 hours versus 5 days. J Trauma 2000;49:822-832.

    Article  CAS  PubMed  Google Scholar 

  11. Schmidt-Matthiesen A, Roding H, Windolf J, Sommerfeldt D, Gutt C, Pannike A, Encke A. A prospective, randomised comparison of single- vs. multiple-dose antibiotic prophylaxis in penetrating trauma. Chemotherapy 1999;45:380-391.

    Article  CAS  PubMed  Google Scholar 

  12. Tyburski JG, Wilson RF, Warsow KM, McCreadie S. A trial of ciprofloxacin and metronidazole vs gentamicin and metronidazole for penetrating abdominal trauma. Arch Surg 1998;133:1289-1296.

    Article  CAS  PubMed  Google Scholar 

  13. Sims EH, Thadepalli H, Ganesan K, Mandal AK. How many antibiotics are necessary to treat abdominal trauma victims? Am Surg 1997;63:525-535.

    CAS  PubMed  Google Scholar 

  14. Demetriades D. Antibiotic prophylaxis in penetrating abdominal injuries. S Afr J Surg 1989;Suppl:5.

  15. Fabian TC, Hoefling SJ, Strom PR, Stone HH. Use of antibiotic prophylaxis in penetrating abdominal trauma. Clin Ther 1982;5 Suppl A:38-47.

    Google Scholar 

  16. Montravers P, Gauzit R, Muller C, Marmuse JP, Fichelle A, Desmonts JM. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 1996;23:486-494.

    CAS  PubMed  Google Scholar 

  17. Mosdell DM, Morris DM, Voltura A, Pitcher DE, Twiest MW, Milne RL, Miscall BG, Fry DE. Antibiotic treatment for surgical peritonitis. Ann Surg 1991;214:543-549.

    Article  CAS  PubMed  Google Scholar 

  18. Sturkenboom MC, Goettsch WG, Picelli G, in 't Veld B, Yin DD, de Jong RB, Go PM, Herings RM. Inappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costs. Br J Clin Pharmacol 2005;60:438-443.

    Article  CAS  PubMed  Google Scholar 

  19. Krobot K, Yin D, Zhang Q, Sen S, Altendorf-Hofmann A, Scheele J, Sendt W. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 2004;23:682-687.

    Article  CAS  PubMed  Google Scholar 

  20. Guembe M, Cercenado E, Alcala L, Marin M, Insa R, Bouza E. Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003-2007. Rev Esp Quimioter 2008;21:166-173.

    CAS  PubMed  Google Scholar 

  21. Montravers P, Lepape A, Dubreuil L, Gauzit R, Pean Y, Benchimol D, Dupont H. Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study. J Antimicrob Chemother 2009;63:785-794.

    Article  CAS  PubMed  Google Scholar 

  22. Velmahos GC, Vassiliu P, Demetriades D, Chan LS, Murray J, Salim A, Sava J, Katkhouda N, Berne TV. Wound management after colon injury: open or closed? A prospective randomized trial. Am Surg 2002;68:795-801.

    PubMed  Google Scholar 

  23. Giannella RA, Broitman SA, Zamcheck N. Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut 1972;13:251-256.

    Article  CAS  PubMed  Google Scholar 

  24. Thadepalli H. Principles and practice of antibiotic therapy for post-traumatic abdominal injuries. Surg Gynecol Obstet 1979;148:937-951.

    CAS  PubMed  Google Scholar 

  25. Durham RM, Olson S, Weigelt JA. Penetrating injuries to the stomach. Surg Gynecol Obstet 1991;172:298-302.

    CAS  PubMed  Google Scholar 

  26. Thadepalli H, Lou MA, Bach VT, Matsui TK, Mandal AK. Microflora of the human small intestine. Am J Surg 1979;138:845-850.

    Article  CAS  PubMed  Google Scholar 

  27. Paterson DL, Rossi F, Baquero F, Hsueh PR, Woods GL, Satishchandran V, Snyder TA, Harvey CM, Teppler H, Dinubile MJ, Chow JW. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother 2005;55:965-973.

    Article  CAS  PubMed  Google Scholar 

  28. Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, Satishchandran V, McCarroll K, DiNubile MJ, Chow JW. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother 2006;58:205-210.

    Article  CAS  PubMed  Google Scholar 

  29. Bochicchio GV, Baquero F, Hsueh PR, Paterson DL, Rossi F, Snyder TA, McCarroll K, Satishchandran V, Dinubile MJ, Chow JW. In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Surg Infect (Larchmt) 2006;7:537-545.

    Article  Google Scholar 

  30. Baquero F, Cercenado E, Cisterna R, de la Rosa M, Garcia-Rodriguez JA, Gobernado M, Perez JL, Manchado P, Martin R, Pascual A, Picazo J, Prats G, Rubio C, Snyder TA, Sanz-Rodriguez C. [Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes]. Rev Esp Quimioter 2006;19:51-59.

    CAS  PubMed  Google Scholar 

  31. Ko WC, Hsueh PR. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006. J Infect 2009;59:95-103.

    Article  PubMed  Google Scholar 

  32. Nijssen S, Florijn A, Bonten MJ, Schmitz FJ, Verhoef J, Fluit AC. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents 2004;24:585-591.

    Article  CAS  PubMed  Google Scholar 

  33. Sotto A, Lefrant JY, Fabbro-Peray P, Muller L, Tafuri J, Navarro F, Prudhomme M, De La Coussaye JE. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother 2002;50:569-576.

    Article  CAS  PubMed  Google Scholar 

  34. Eagye KJ, Kim A, Laohavaleeson S, Kuti JL, Nicolau DP. Surgical site infections: does inadequate antibiotic therapy affect patient outcomes? Surg Infect (Larchmt) 2009;10:323-331.

    Article  Google Scholar 

  35. Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, Buchman T, Dellinger EP, Jernigan J, Gorbach S, Chow AW, Bartlett J. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 2003;37:997-1005.

    Article  PubMed  Google Scholar 

  36. Burnett RJ, Haverstock DC, Dellinger EP, Reinhart HH, Bohnen JM, Rotstein OD, Vogel SB, Solomkin JS. Definition of the role of Enterococcus in intraabdominal infection: analysis of a prospective randomized trial. Surgery 1995;118:716-721

    Article  CAS  PubMed  Google Scholar 

  37. Christou NV, Turgeon P, Wassef R, Rotstein O, Bohnen J, Potvin M. Management of intra-abdominal infections. The case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intra-abdominal Infection Study Group. Arch Surg 1996;131:1193-1201.

    CAS  PubMed  Google Scholar 

  38. Weigelt JA, Easley SM, Thal ER, Palmer LD, Newman VS. Abdominal surgical wound infection is lowered with improved perioperative Enterococcus and Bacteroides therapy. J Trauma 1993;34:579-584

    Article  CAS  PubMed  Google Scholar 

  39. Sitges-Serra A, Lopez MJ, Girvent M, Almirall S, Sancho JJ. Postoperative enterococcal infection after treatment of complicated intra-abdominal sepsis. Br J Surg 2002;89:361-367.

    Article  CAS  PubMed  Google Scholar 

  40. Roehrborn A, Thomas L, Potreck O, Ebener C, Ohmann C, Goretzki PE, Roher HD. The microbiology of postoperative peritonitis. Clin Infect Dis 2001;33:1513-1519.

    Article  CAS  PubMed  Google Scholar 

  41. Seguin P, Laviolle B, Chanavaz C, Donnio PY, Gautier-Lerestif AL, Campion JP, Malledant Y. Factors associated with multidrug-resistant bacteria in secondary peritonitis: impact on antibiotic therapy. Clin Microbiol Infect 2006;12:980-985.

    Article  CAS  PubMed  Google Scholar 

  42. Reik R, Tenover FC, Klein E, McDonald LC. The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004. Diagn Microbiol Infect Dis 2008;62:81-85.

    Article  PubMed  Google Scholar 

  43. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 2003;36:1433-1437.

    Article  PubMed  Google Scholar 

  44. Eliopoulos GM. Quinupristin-dalfopristin and linezolid: evidence and opinion. Clin Infect Dis 2003;36:473-481.

    Article  PubMed  Google Scholar 

  45. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000;342:710-721.

    Article  CAS  PubMed  Google Scholar 

  46. Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006;42:389-391.

    Article  PubMed  Google Scholar 

  47. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007;13:1840-1846.

    PubMed  Google Scholar 

Download references

Conflicts of interest

The authors have no conflict of interest to report and have received no financial or material support related to this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenji Inaba.

Additional information

Oral Presentation at the American College of Surgeons, Southern California Chapter Meeting, January 2010, Santa Barbara, California, USA.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schnüriger, B., Inaba, K., Eberle, B.M. et al. Microbiological Profile and Antimicrobial Susceptibility in Surgical Site Infections Following Hollow Viscus Injury. J Gastrointest Surg 14, 1304–1310 (2010). https://doi.org/10.1007/s11605-010-1231-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-010-1231-x

Keywords

Navigation